V-Myc immortalizes human neural stem cells in the absence of pluripotency-associated traits

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Pino Barrio, María José ^a,d   García García, Elisa ^a,e   Menéndez, Pablo ^b,c   Martínez Serrano, Alberto ^a  

^a CSIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

^d CIEMAT   (Spain)

^e Howard Hughes Medical Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; MYC PROTEIN; PROTEIN V MYC; UNCLASSIFIED DRUG; GENETIC MARKER; ONCOPROTEIN;

ARTICLE; CELL IMMORTALIZATION; CELL RENEWAL; CLUSTER ANALYSIS; CONTROLLED STUDY; EMBRYONIC STEM CELL; ENZYME ACTIVITY; FETUS; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCYTOCHEMISTRY; NEURAL STEM CELL; PRINCIPAL COMPONENT ANALYSIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; COMPARATIVE STUDY; CYTOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; METABOLISM; MULTIPOTENT STEM CELL; PHYSIOLOGY; PROCEDURES;

CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CLUSTER ANALYSIS; EMBRYONIC STEM CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKERS; HUMANS; MULTIPOTENT STEM CELLS; NEURAL STEM CELLS; ONCOGENE PROTEIN P55(V-MYC); PRINCIPAL COMPONENT ANALYSIS;

EID: 84928911085     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118499     Document Type: Article

References (43)

1. Gage FH, Temple S. Neural stem cells: Generating and regenerating the brain. Neuron 2013; 80: 588-601.
2. Brambrink T, Foreman R, Welstead GG, Lengner CJ, Wernig M, et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell 2008; 2:151-159. doi: 10.1016/j.stem.2008.01.004 PMID: 18371436
3. Stadtfeld M, Maherali N, Breault DT, Hochedlinger K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2008; 2: 230-240. doi: 10.1016/j.stem.2008.02. 001 PMID: 18371448
4. Martinez-Serrano A, Bjorklund A. Immortalized neural progenitor cells for CNS gene transfer and repair. Trends Neurosci. 1997; 20:530-538. PMID: 9364668
5. Martínez-Serrano A, Snyder EY. Neural stem cell lines for CNS repair. In "CNS Regeneration: Basic science and clinical applications". 1998. Tuszynski M, Kordower J y Bankiewicz J, eds. Academic Press, San Diego, CA; pp203-250.
6. Meyer N, Penn LZ. Reflecting on 25 years with MYC. Nat Rev Cancer 2008; 8: 976-990. doi: 10.1038/ nrc2231 PMID: 19029958
7. Villa A, Snyder EY, Vescovi A, Martinez-Serrano A. Establishment and properties of a growth factor-dependent, perpetual neural stem cell line from the human CNS. Exp Neurol, 2000; 161: 67-84. PMID: 10683274
8. Villa A, Navarro-Galve B, Bueno C, Franco S, Blasco MA, Martinez-Serrano A. Long-term molecular and cellular stability of human neural stem cell lines. Exp Cell Res, 2004; 294: 559-570. PMID: 15023542
9. Kim KS, Lee HJ, Jeong HS, Li J, Teng YD, Sidman RL, et al. Self-renewal induced efficiently, safely, and effective therapeutically with one regulatable gene in a human somatic progenitor cell. Proc Natl Acad Sci U S A 2011; 108: 4876-4881. doi: 10.1073/pnas.1019743108 PMID: 21378266
10. Polo JM, Anderssen E, Walsh RM, Schwarz BA, Nefzger CM, Lim SM, et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell 2012; 151: 1617-1632. doi: 10.1016/j.cell.2012.11.039 PMID: 23260147
11. Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat Biotechnol, 2008; 26: 101-106. PMID: 18059259
12. Wernig M, Meissner A, Cassady JP, Jaenisch R. c-Myc is dispensable for direct reprogramming of mouse fibroblasts. Cell Stem Cell 2008; 2: 10-12.
13. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat Biotechnol, 2007; 25: 1177-1181. PMID: 17724450
14. Park IH, Zhao R, West JA, Yabuuchi A, Huo H, Ince TA, et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008; 451: 141-146. PMID: 18157115
15. Singh AM, Dalton S. The cell cycle and Myc intersect with mechanisms that regulate pluripotency and reprogramming. Cell Stem Cell 2009); 5:141-149. doi: 10.1016/j.stem.2009.07.003 PMID: 19664987
16. Smith KN, Singh AM, Dalton S. Myc represses primitive endoderm differentiation in pluripotent stem cells. Cell Stem Cell 2010; 7: 343-354. doi: 10.1016/j.stem.2010.06.023 PMID: 20804970
17. Knoepfler PS. Why myc? An unexpected ingredient in the stem cell cocktail. Cell Stem Cell 2008; 2: 18-21. doi: 10.1016/j.stem.2007.12.004 PMID: 18371417
18. Yamanaka S. Elite and stochastic models for induced pluripotent stem cell generation. Nature 2009; 460: 49-52. doi: 10.1038/nature08180 PMID: 19571877
19. Knoepfler PS, Zhang XY, Cheng PF, Gafken PR, McMahon SB, Eisenman RN. Myc influences global chromatin structure. Embo J, 2006; 25: 2723-2734.
20. Varlakhanova NV, Knoepfler PS. Acting locally and globally: Myc's ever-expanding roles on chromatin. Cancer Res, 2009; 69: 7487-7490. doi: 10.1158/0008-5472.CAN-08-4832 PMID: 19773445
21. Knoepfler PS. Myc goes global: new tricks for an old oncogene. Cancer Res, 2007; 67: 5061-5063. PMID: 17545579
22. Zornig M, Evan GI. Cell cycle: on target with Myc. Curr Biol, 1996; 6: 1553-1556. PMID: 8994810
23. Takahashi K. Direct reprogramming. Dev Growth Differ, 2010; 52: 319-333. doi: 10.1111/j.1440-169X. 2010.01169.x PMID: 20298260
24. Ramos-Mejia V, Melen GJ, Sanchez L, Gutierrez-Aranda I, Ligero G, Cortes JL, et al. Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage. Mol Ther, 2010; 18: 2173-2181. doi: 10.1038/mt.2010.179 PMID: 20736931
25. Real PJ, Ligero G, Ayllon V, Ramos-Mejia V, Bueno C, Gutierrez-Aranda I, et al. SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells. Mol Ther, 2012; 20: 1443-1453. doi: 10.1038/mt.2012.49 PMID: 22491213
26. Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, et al. Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol, 2007; 25: 803-816. PMID: 17572666
27. Sridharan R, Tchieu J, Mason MJ, Yachechko R, Kuoy E, Horvath S, et al. Role of the murine reprogramming factors in the induction of pluripotency. Cell 2009; 136: 364-377. doi: 10.1016/j.cell.2009. 01.001 PMID: 19167336
28. Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 2008; 454: 49-55. doi: 10.1038/nature07056 PMID: 18509334
29. Kim JB, Sebastiano V, Wu G, Arauzo-Bravo MJ, Sasse P, Gentile L, et al. Oct4-induced pluripotency in adult neural stem cells. Cell 2009; 136: 411-419.
30. Na J, Plews J, Li J, Wongtrakoongate P, Tuuri T, Feki A, et al. Molecular mechanisms of pluripotency and reprogramming. Stem Cell Res Ther, 2010); 1: 33.
31. Masui S, Nakatake Y, Toyooka Y, Shimosato D, Yagi R, Takahashi K, et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol, 2007; 9: 625-635. PMID: 17515932
32. Greenberg RA, O'Hagan RC, Deng H, Xiao Q, Hann SR, Adams RR, et al. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation. Oncogene 1999; 18: 1219-1226. PMID: 10022128
33. Hirasaki M, Hiraki-Kamon K, Kamon M, Suzuki A, Katano M, Nishimoto M, et al. Striking Similarity in the Gene Expression Levels of Individual Myc Module Members among ESCs, EpiSCs, and Partial iPSCs. PLoS One 2013; 8: e83769. doi: 10.1371/journal.pone.0083769 PMID: 24386274
34. Martinez-Serrano A, Rubio FJ, Navarro B, Bueno C, Villa A. Human neural stem and progenitor cells: in vitro and in vivo properties, and potential for gene therapy and cell replacement in the CNS. Curr Gene Ther, 2001; 1: 279-299. PMID: 12109143
35. Martínez-Serrano A, Liste I. Recent progress and challenges for the use of stem cell derivatives in neuron replacement therapy of Parkinson's disease. Future Neurol. 2010; 5: 161-65.
36. Jandial R, Snyder EY. A safer stem cell: on guard against cancer. Nat Med, 2009; 15: 999-1001. doi: 10.1038/nm0909-999 PMID: 19734873
37. Cacci E, Villa A, Parmar M, Cavallaro M, Mandahl N, Lindvall O, et al. Generation of human cortical neurons from a new immortal fetal neural stem cell line. Exp Cell Res, 2007; 313. 588-601. PMID: 17156776
38. Villa A, Rubio FJ, Navarro B, Bueno C, Martinez-Serrano A. Human neural stem cells in vitro. A focus on their isolation and perpetuation. Biomed Pharmacother, 2001; 55: 91-95. PMID: 11293818
39. Villa A, Navarro B, Martinez-Serrano A. Genetic perpetuation of in vitro expanded human neural stem cells: cellular properties and therapeutic potential. Brain Res Bull, 2002; 57: 789-794. PMID: 12031275
40. Villa A, Liste I, Courtois ET, Seiz EG, Ramos M, Meyer M, et al. Generation and properties of a new human ventral mesencephalic neural stem cell line. Exp Cell Res, 2009; 315: 1860-1874. doi: 10. 1016/j.yexcr.2009.03.011 PMID: 19327351
41. Hovatta O, Mikkola M, Gertow K, Stromberg AM, Inzunza J, Hreinsson J, et al. A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod, 2003; 18: 1404-1409.
42. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998; 282: 1145-1147. PMID: 9804556
43. Garcia-Garcia E, Pino-Barri MJ, Lopez-Medina L, Martinez-Serrano A. Intermediate progenitors are increased by lengthening of the cell cycle through calcium signaling and p53 expression in human neural progenitors. Mol Biol Cell, 2012; 23: 1167-1180. doi: 10.1091/mbc.E11-06-0524 PMID: 22323293